GSK, Pfizer Lock Horns Over Patent Fight Related To Respiratory Syncytial Virus Vaccine - GSK (NYSE:GSK), Pfizer (NYSE:PFE)
GSK Plc (NYSE: GSK) has sued Pfizer Inc (NYSE: PFE) in Delaware court, alleging that Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violates GSK's four patent rights in its RSV